Furthermore, a large population-based study strongly suggests a lowered risk for PCa among users of drugs with HDAC inhibitory activity, with a slight reduction of the overall PCa risk for men stratified by the concomitant use of statins [76]. The gene discussed is HDAC9; the disease is posterior cortical atrophy.